Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10914285 | 0.89 | MAPT (0.45) | MAPTCYP1A2CYP2C9HPGDMAPK1 | |
| SCHEMBL5959237 | 0.86 | CYP1A2 (0.52) | MAPTCYP1A2CYP2C9HPGDMAPK1 | |
| SCHEMBL17401300 | 0.86 | MAPT (0.47) | MAPTCYP1A2CYP2C9HPGDMAPK1 | |
| SCHEMBL9388290 | 0.86 | CA12 (0.47) | MAPTALDH1A1KDM4ESIGMAR1CA12 | |
| SCHEMBL11724032 | 0.85 | MAPT (0.38) | MAPTCYP1A2CYP2C9HPGDMAPK1 | |
| SCHEMBL3426889 | 0.85 | ALDH1A1 (0.37) | MAPTCYP1A2CYP2C9HPGDMAPK1 | |
| SCHEMBL13201991 | 0.83 | MAPT (0.45) | MAPTCYP1A2CYP2C9HPGDMAPK1 | |
| SCHEMBL20835926 | 0.83 | MAPT (0.45) | MAPTCYP1A2CYP2C9HPGDMAPK1 | |
| SCHEMBL13989311 | 0.83 | MAPT (0.45) | MAPTCYP1A2CYP2C9HPGDMAPK1 | |
| SCHEMBL12295466 | 0.83 | MAPT (0.45) | MAPTCYP1A2CYP2C9HPGDMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2878609-B1 | AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND AND POLYISOCYANATE ADHESIVE COMPOSITION CONTAINING AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND | TOSOH CORP (JP) | 2019-06-05 | — | — | EP | claimed |
| US-9777199-B2 | Amine catalyst for curing polyisocyanate compound and polyisocyanate adhesive composition containing amine catalyst for curing polyisocyanate compound | TOSOH CORPORATION (JP) | 2017-10-03 | — | — | US | claimed |
| US-20150203727-A1 | AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND AND POLYISOCYANATE ADHESIVE COMPOSITION CONTAINING AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND | TOSOH CORPORATION (JP) | 2015-07-23 | — | — | US | claimed |
| EP-2878609-A1 | AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND AND POLYISOCYANATE ADHESIVE COMPOSITION CONTAINING AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND | Tosoh Corporation (JP) | 2015-06-03 | — | — | EP | claimed |
| US-20260102348-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2026-04-16 | — | — | US | disclosed |
| US-12508226-B2 | Lipid composition | FUJIFILM CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| US-12370143-B2 | Compound or salt thereof and lipid particles | FUJIFILM CORPORATION (JP) | 2025-07-29 | — | — | US | disclosed |
| EP-4328309-B1 | LIPID COMPOSITION | FUJIFILM CORP (JP) | 2025-07-02 | — | — | EP | disclosed |
| US-12285525-B2 | Compound or salt thereof and lipid particles | FUJIFILM CORPORATION (JP) | 2025-04-29 | — | — | US | disclosed |
| CN-116172975-B | Lipid particle, nucleic acid drug comprising same, and composition for nucleic acid delivery | 富士胶片株式会社 | 2025-03-28 | — | — | CN | disclosed |
| CN-114728016-B | Lipid composition | 富士胶片株式会社 | 2024-10-29 | — | — | CN | disclosed |
| US-20240315970-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2024-09-26 | — | — | US | disclosed |
| WO-2016178793-A1 | DELAYED ACTION GELLING CATALYST COMPOSITIONS AND METHODS FOR MAKING POLYURETHANE POLYMERS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-11-10 | — | — | WO | disclosed |
| US-9139609-B2 | C-4″ position substituted macrolide derivative | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2015-09-22 | — | — | US | disclosed |
| US-20150203727-A1 | AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND AND POLYISOCYANATE ADHESIVE COMPOSITION CONTAINING AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND | TOSOH CORPORATION (JP) | 2015-07-23 | — | — | US | disclosed |
| EP-2878609-A1 | AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND AND POLYISOCYANATE ADHESIVE COMPOSITION CONTAINING AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND | Tosoh Corporation (JP) | 2015-06-03 | — | — | EP | disclosed |
| US-8933223-B2 | Process for preparing a cyclic tertiary amine | BASF SE (DE) | 2015-01-13 | — | — | US | disclosed |
| US-20140046043-A1 | C-4\" POSITION SUBSTITUTED MACROLIDE DERIVATIVE | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2014-02-13 | — | — | US | disclosed |
| US-4048322-A | Bronchially effective xanthene-9-carboxylates | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1977-09-13 | — | — | US | disclosed |
| US-4044146-A | CHOLINOLYTIC, BRONCHOSPASMOLYTIC | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1977-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12370143-B2 | Compound or salt thereof and lipid particles | NR1H3, NR1H2, LDLR | MAPT 4495/4885CYP1A2 1806/4885CYP2C9 1329/4885 |
| US-12285525-B2 | Compound or salt thereof and lipid particles | NR1H3, NR1H2, LDLR | MAPT 4495/4885CYP1A2 1806/4885CYP2C9 1329/4885 |
| US-20240315970-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | NR1H3, NR1H2, LDLR | MAPT 4495/4885CYP1A2 1806/4885CYP2C9 1329/4885 |
| US-20260102348-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | LDLR, NR1H3, NR1H2 | MAPT 4284/4885CYP1A2 3645/4885CYP2C9 3691/4885 |
| US-20140046043-A1 | C-4\" POSITION SUBSTITUTED MACROLIDE DERIVATIVE | MRPL21, MRPS34, MRPL37 | MAPT 3750/4885CYP1A2 1987/4885CYP2C9 836/4885 |
| US-12508226-B2 | Lipid composition | APOB, NAF1, SLC27A1 | MAPT 3749/4885CYP1A2 4015/4885CYP2C9 3085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.